halls mentho lyptus cough tab tablet
adams canada, division of warner-lambert canada inc. - eucalyptus oil; menthol - tablet - 6.2mg; 10.9mg - eucalyptus oil 6.2mg; menthol 10.9mg - other cold and cough preparations
halls mentho lyptus cough tab black currant lozenge
adams canada, division of warner-lambert canada inc. - menthol; eucalyptus oil - lozenge - 7.2mg; 6.5mg - menthol 7.2mg; eucalyptus oil 6.5mg - other cold and cough preparations
rolaids tablet
adams canada, division of warner-lambert canada inc. - calcium carbonate; magnesium hydroxide - tablet - 317mg; 64mg - calcium carbonate 317mg; magnesium hydroxide 64mg - antacids and adsorbents
naproxen capsules 200 mg
accucaps industries limited - naproxen sodium; naproxen - capsule - 105mg; 105mg - naproxen sodium 105mg; naproxen 105mg - other nonsteroidal antiimflammatory agents
cipla isoprenaline isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule
cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).
isoprenaline hydrochloride medsurge isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule
medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).
isoprenaline hydrochloride medsurge isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule
medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; hydrochloric acid; sodium chloride; disodium edetate; citric acid; water for injections - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).
cipla isoprenaline isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule
cipla australia pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).
isoprenaline macure isoprenaline hydrochloride 1 mg/5 ml solution for injection ampoule
juno pharmaceuticals pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; water for injections; sodium hydroxide; hydrochloric acid; sodium chloride; citric acid monohydrate; disodium edetate - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications.) for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.) for bronchospasm occurring during anaesthesia. as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use)
bactigent 500 mg capsule
hexagon pharmaceuticals; distributor: filadams pharma inc - amoxicillin (as trihydrate) - capsule - 500 mg